4th Quarter - Report

COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS, LLC) for COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS LLC)

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

No specific provisions lobbied - General Support of passage for S. 3084 - American Innovation and Competitiveness Act, S. 289 - The American Cures Act and H.R. 6 - The 21st Century Cure Act Education about Marathon Pharmaceuticals future products (if approved by FDA). Education about Marathon Pharmaceuticals initiatives, role in rare diseases, precision medicine and sale of legacy products.

LobbyistCovered position, as disclosed
GREGORY ARONIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), S. 289 (114th), S. 3084 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.